Nicola Galea1,2, Gian Marco Dacquino1, Rosa Maria Ammendola1, Simona Coco1, Luciano Agati3, Laura De Luca3, Iacopo Carbone1, Francesco Fedele3, Carlo Catalano1, Marco Francone4. 1. Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome "Sapienza", Viale Regina Elena 324, 00161, Rome, Italy. 2. Department of Experimental Medicine, University of Rome "Sapienza", Rome, Italy. 3. Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome "Sapienza", Rome, Italy. 4. Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome "Sapienza", Viale Regina Elena 324, 00161, Rome, Italy. marco.francone@uniroma1.it.
Abstract
OBJECTIVES: To investigate the prognostic role of early post-infarction cardiac magnetic resonance (CMR) on long-term risk stratification of ST segment elevation myocardial infarction (STEMI) patients with preserved left ventricular ejection fraction (LVEF). METHODS: Seventy-seven STEMI patients treated by primary percutaneous coronary intervention (PCI) and LVEF > 50% at CMR were included. The median time between STEMI and CMR was 5 days (IQR 2-8). LV volumes and function, area at risk (on T2 weighted images), infarcted myocardium (on late enhanced images), intramyocardial hemorrhage, and early and late microvascular obstruction (MVO) were detected and measured. CMR tissue determinants were correlated with the incidence of major adverse cardiovascular events (MACEs) over a 5-year follow-up. RESULTS: During median follow-up of 4 years (range 3 to 5 years), eight (10%) patients experienced MACE, yielding an annualized event rate of 2.1%. All CMR tissue markers were not significantly different between MACE and no-MACE patients, except for the presence of late MVO (50% vs. 16%, respectively; p = 0.044) and its extent (2.30 ± 1.64 g vs. 0.18 ± 0.12 g, respectively; p = 0.000). From receiver-operating characteristic (ROC) curve (area under the curve 0.89; 95% confidence interval, 0.75-1.0; p = 0.000), late MVO extent > 0.385 g was a strong independent predictor of MACE at long-term follow-up (sensitivity = 87%, specificity = 90%; hazard ratio = 2.24; 95% confidence interval, 1.51-3.33; p = 0.000). CONCLUSIONS: Late MVO extent after primary PCI on CMR seems to be a strong predictor of MACE at 5-year follow-up in patients with LVEF > 50%. Noticeably, late MVO extent > 0.385 g provided relevant prognostic insights leading to improved long-term risk stratification. KEY POINTS: • Tissue markers provided by cardiac magnetic resonance aid in prognostic stratification after myocardial infarction • The occurrence of late microvascular obstruction after acute myocardial infarction increases risk of major adverse events at 5-year follow-up. • The greater microvascular obstruction extent on late gadolinium enhanced images is related to an increased risk of adverse events in patients with myocardial infarction and preserved left ventricular function.
OBJECTIVES: To investigate the prognostic role of early post-infarction cardiac magnetic resonance (CMR) on long-term risk stratification of ST segment elevation myocardial infarction (STEMI) patients with preserved left ventricular ejection fraction (LVEF). METHODS: Seventy-seven STEMI patients treated by primary percutaneous coronary intervention (PCI) and LVEF > 50% at CMR were included. The median time between STEMI and CMR was 5 days (IQR 2-8). LV volumes and function, area at risk (on T2 weighted images), infarcted myocardium (on late enhanced images), intramyocardial hemorrhage, and early and late microvascular obstruction (MVO) were detected and measured. CMR tissue determinants were correlated with the incidence of major adverse cardiovascular events (MACEs) over a 5-year follow-up. RESULTS: During median follow-up of 4 years (range 3 to 5 years), eight (10%) patients experienced MACE, yielding an annualized event rate of 2.1%. All CMR tissue markers were not significantly different between MACE and no-MACE patients, except for the presence of late MVO (50% vs. 16%, respectively; p = 0.044) and its extent (2.30 ± 1.64 g vs. 0.18 ± 0.12 g, respectively; p = 0.000). From receiver-operating characteristic (ROC) curve (area under the curve 0.89; 95% confidence interval, 0.75-1.0; p = 0.000), late MVO extent > 0.385 g was a strong independent predictor of MACE at long-term follow-up (sensitivity = 87%, specificity = 90%; hazard ratio = 2.24; 95% confidence interval, 1.51-3.33; p = 0.000). CONCLUSIONS: Late MVO extent after primary PCI on CMR seems to be a strong predictor of MACE at 5-year follow-up in patients with LVEF > 50%. Noticeably, late MVO extent > 0.385 g provided relevant prognostic insights leading to improved long-term risk stratification. KEY POINTS: • Tissue markers provided by cardiac magnetic resonance aid in prognostic stratification after myocardial infarction • The occurrence of late microvascular obstruction after acute myocardial infarction increases risk of major adverse events at 5-year follow-up. • The greater microvascular obstruction extent on late gadolinium enhanced images is related to an increased risk of adverse events in patients with myocardial infarction and preserved left ventricular function.
Entities:
Keywords:
Acute myocardial infarction; Cardiac magnetic resonance; Left ventricular ejection fraction; Major adverse cardiovascular events; Microvascular obstruction
Authors: Olga Bondarenko; Aernout M Beek; Mark B M Hofman; Harald P Kühl; Jos W R Twisk; Willem G van Dockum; Cees A Visser; Albert C van Rossum Journal: J Cardiovasc Magn Reson Date: 2005 Impact factor: 5.364
Authors: Timo Baks; Robert-Jan van Geuns; Elena Biagini; Piotr Wielopolski; Nico R Mollet; Filippo Cademartiri; Willem J van der Giessen; Gabriel P Krestin; Patrick W Serruys; Dirk J Duncker; Pim J de Feyter Journal: J Am Coll Cardiol Date: 2005-12-09 Impact factor: 24.094
Authors: Javier Ganame; Giancarlo Messalli; Steven Dymarkowski; Frank E Rademakers; Walter Desmet; Frans Van de Werf; Jan Bogaert Journal: Eur Heart J Date: 2009-04-03 Impact factor: 29.983
Authors: Matthijs van Kranenburg; Michael Magro; Holger Thiele; Suzanne de Waha; Ingo Eitel; Alexandre Cochet; Yves Cottin; Dan Atar; Peter Buser; Edwin Wu; Daniel Lee; Vicente Bodi; Gert Klug; Bernhard Metzler; Ronak Delewi; Peter Bernhardt; Wolfgang Rottbauer; Eric Boersma; Felix Zijlstra; Robert-Jan van Geuns Journal: JACC Cardiovasc Imaging Date: 2014-09
Authors: Gjin Ndrepepa; Julinda Mehilli; Stefan Martinoff; Markus Schwaiger; Albert Schömig; Adnan Kastrati Journal: J Am Coll Cardiol Date: 2007-06-21 Impact factor: 24.094
Authors: David Carrick; Caroline Haig; Sam Rauhalammi; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Stuart Watkins; Stuart Hood; Andrew Davie; Ahmed Mahrous; Naveed Sattar; Paul Welsh; Niko Tzemos; Aleksandra Radjenovic; Ian Ford; Keith G Oldroyd; Colin Berry Journal: JACC Cardiovasc Imaging Date: 2015-06-17
Authors: Han Wu; Ran Li; Kun Wang; Dan Mu; Jian-Zhou Chen; Xuan Wei; Xue Bao; Zhong-Hai Wei; Jun Xie; Biao Xu Journal: Cardiol Res Pract Date: 2020-09-26 Impact factor: 1.866
Authors: Domenico Filomena; Sara Cimino; Sara Monosilio; Nicola Galea; Giuseppe Mancuso; Marco Francone; Giovanni Tonti; Gianni Pedrizzetti; Viviana Maestrini; Francesco Fedele; Luciano Agati Journal: ESC Heart Fail Date: 2021-12-23
Authors: Camilla Calvieri; Nicola Galea; Francesco Cilia; Giacomo Pambianchi; Giuseppe Mancuso; Domenico Filomena; Sara Cimino; Iacopo Carbone; Marco Francone; Luciano Agati; Carlo Catalano Journal: Front Cardiovasc Med Date: 2022-03-16
Authors: Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs Journal: Eur Heart J Date: 2022-07-14 Impact factor: 35.855
Authors: Mirunalini Thirugnanasambandam; Sabrina Frey; Yannick Rösch; Alberto Mantegazza; Francesco Clavica; Robert S Schwartz; Nikola Cesarovic; Dominik Obrist Journal: Ann Biomed Eng Date: 2022-05-31 Impact factor: 4.219